Dr. Galsky on Progression on Immunotherapy in Bladder Cancer

(59)

Dr. Galsky Discusses Neoadjuvant Immunotherapy in Bladder Cancer

(1:36)

Dr. Galsky Discusses Combination Immunotherapy in Bladder Cancer

(1:58)

Dr. Galsky on Targeted Therapies in Bladder Cancer

(2:3)

മാരക രോഗങ്ങൾക്ക് വിട - ന്യൂട്രീഷൻ ചികിത്സയിലൂടെ അത്ഭുത രോഗശാന്തി EXCLUSIVE INTERVIEW DR.A.SREEKUMAR

(31:55)

Breakthroughs in Prostate and Bladder Cancer Treatment - Full Video

(48:37)

อย่านิ่งนอนใจ! อาการเตือนโรคระบบทางเดินปัสสาวะ | บำรุงราษฎร์

(5:19)

Cancer Treatment in CKD Patients - Prof. Dr. Sabine Karam, Prof. Dr. Jolanta Małyszko

(57:30)

Deciphering Immuno-Oncology: Targeting Cellular Mechanisms of the Tumor Immune Response

(1:2:29)

30% of stage 4 bladder cancer patients can now go on to live beyond five years: Dr. Shyam Aggarwal

(4:31)

Patient and Doctor Testimonial: Dr. Mackey \u0026 Mike

(5:51)

How is Advanced Bladder Cancer Treated?

(6:46)

Nivo+Gem/Cis Is Durable, Improves Survival in Patients With Lymph Node–Only mUC

(7:52)

Understanding Bladder Cancer | The Basics of Metastatic Bladder Cancer

(18:36)

Dr. Galsky on the Geographic Accessibility of Prostate Cancer Clinical Trials

(2:10)

Dr. Galsky on the Role of Ipilimumab in Bladder Cancer

(1:9)

Dr. Matthew Galsky - ASCO 2021

(4:22)

Dr. Galsky Discusses the Rationale for the IMvigor130 Study in Bladder Cancer

(2:19)

Dr. Galsky on Neoadjuvant Immune Checkpoint Blockade in Bladder Cancer

(1:35)

Dr. Galsky on Ipilimumab in Bladder Cancer

(1:7)

Matthew Galsky, MD, shares a message for patients regarding clinical progress in bladder cancer

(1:8)

Dr. Matthew Galsky on abiraterone

(3:17)

Matthew Galsky Gives an Overview of Bladder Cancer

(1:35)

ASCO GU 2020: Dr. Galsky Provides Insight on Potentially Practice-Changing Studies in Bladder Cancer

(7:40)

Matthew Galsky, MD, discusses how to identify patients that will likely be good responders for I-O

(2:14)

ESMO Dr. Galsky

(2:52)

Dr. Galsky on Resistance to Checkpoint Blockade in Metastatic Bladder Cancer

(59)

Galsky: Adjuvant Chemo vs. Observation in Bladder Cancer

(2:34)

Dr. Galsky on Maintenance Pembrolizumab in Urothelial Cancer

(2:21)

Breakthroughs in Bladder Cancer Immunotherapy, with Matthew Galsky

(44:28)